From May 12, 2022 to June 30, 2022, the company has repurchased 797,000 shares, representing 0.14% for HKD 2.9 million. With this, the company has completed the repurchase of 797,000 shares, representing 0.14% for HKD 2.9 million under the buyback announced on May 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.45 HKD | +2.51% | -3.92% | -1.61% |
May. 28 | Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2023 | CI |
Mar. 19 | Essex Bio-Technology's 2023 Profit Jumps 22% on Higher Turnover | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.61% | 174M | |
+2.22% | 94.37B | |
-0.66% | 38.14B | |
-13.57% | 32.56B | |
+76.24% | 28.24B | |
-12.73% | 15.98B | |
-2.15% | 13.82B | |
-13.59% | 11.57B | |
+158.88% | 10.52B | |
-52.04% | 9.89B |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.